Jane Street
MRNA icon

Jane Street’s Moderna MRNA Stock Holding History

Jane Street’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229M Buy
4,517,500
+173,700
+4% +$8.1M 0.03% 354
2025
Q4 		$128M Sell
4,343,800
-677,300
-13% -$18.4M 0.02% 478
2025
Q3 		$130M Buy
5,021,100
+726,100
+17% +$20.3M 0.02% 473
2025
Q2 		$118M Buy
4,295,000
+1,009,300
+31% +$26.6M 0.02% 415
2025
Q1 		$93.1M Buy
3,285,700
+1,144,500
+53% +$40.6M 0.02% 406
2024
Q4 		$89M Buy
2,141,200
+1,053,800
+97% +$50.4M 0.02% 465
2024
Q3 		$72.7M Buy
1,087,400
+103,100
+10% +$9.47M 0.02% 512
2024
Q2 		$117M Buy
984,300
+88,900
+10% +$11.3M 0.03% 347
2024
Q1 		$95.4M Buy
895,400
+70,600
+9% +$7.12M 0.02% 382
2023
Q4 		$82M Buy
824,800
+11,700
+1% +$984K 0.02% 467
2023
Q3 		$84M Sell
813,100
-85,300
-9% -$9.51M 0.03% 380
2023
Q2 		$109M Buy
898,400
+287,200
+47% +$38.3M 0.04% 306
2023
Q1 		$93.9M Sell
611,200
-461,800
-43% -$76.2M 0.04% 317
2022
Q4 		$193M Buy
1,073,000
+18,600
+2% +$3.04M 0.09% 145
2022
Q3 		$125M Sell
1,054,400
-105,200
-9% -$16M 0.05% 217
2022
Q2 		$166M Sell
1,159,600
-710,200
-38% -$102M 0.07% 182
2022
Q1 		$322M Sell
1,869,800
-1,311,500
-41% -$221M 0.1% 105
2021
Q4 		$808M Buy
3,181,300
+944,200
+42% +$276M 0.27% 39
2021
Q3 		$861M Buy
2,237,100
+978,100
+78% +$361M 0.3% 35
2021
Q2 		$296M Buy
1,259,000
+112,300
+10% +$20.1M 0.12% 110
2021
Q1 		$150M Sell
1,146,700
-86,600
-7% -$12.5M 0.07% 185
2020
Q4 		$129M Buy
1,233,300
+99,800
+9% +$10.1M 0.06% 195
2020
Q3 		$80.2M Buy
1,133,500
+359,000
+46% +$25M 0.05% 271
2020
Q2 		$49.7M Buy
774,500
+549,200
+244% +$30.1M 0.04% 358
2020
Q1 		$6.75M Buy
+225,300
New +$5.18M 0.01% 999

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's MRNA Position: Q1 2026 in Review

Jane Street increased its Moderna (MRNA) stake by 78% in Q1 2026, buying an estimated $804K and bringing the position to 39,463 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #5091.

Jane Street first reported a position in MRNA in Q4 2018 and has held it in 27 quarters since. The position peaked at $340M in Q4 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Jane Street held 39,463 shares of Moderna worth $2M as of Q1 2026.
  • Jane Street bought 17,235 Moderna shares in Q1 2026, an estimated $804K.
  • Moderna made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5091 holding.
  • Jane Street first reported a position in Moderna in Q4 2018 and has held it in 27 quarters since.
  • Jane Street's Moderna position peaked at $340M in Q4 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.